Biodefense Main


Open-architecture xMAP® technology allows simultaneous detection of bacterial, viral and toxin agents, in a highly flexible, multiplexed architecture capable of protein and nucleic acid assay formats. The xMAP suspension array technology enables multiplex identification of up to 500 analytes in a single reaction using small sample volumes. The microsphere technology platform offers expansion capability, wherein newly discovered agent threats could be added to an existing panel with relative ease by adding new microsphere sets coupled to specific detection moieties. In addition to high multiplexing, thousands of microspheres from each region are used to detect each target in a single mix, yielding significant improvements in statistical accuracy. xMAP allows you to do more with less.